Literature DB >> 33210487

[Reuse process of positive pressure powered air-filter protective hoods].

Junjun Mo1, Fang Huang1, Bei Lyu1, Hongmei Shen1, Qun Wang1, Xiaowei Xu1, Qinming Chai1.   

Abstract

OBJECTIVE: To establish reuse process of positive pressure powered air-filter protective hoods during coronavirus disease 2019 (COVID-19) epidemic.
METHODS: The procedure of pretreatment, storage, recovery, cleaning, disinfection and sterilization process of positive pressure powered air-filter protective hoods, which were used in the treatment of COVID-19 infection patients was established in Central Sterile Supply Department of the hospital. The cleaning and disinfection effects of the protective hoods after treatment were examined by magnifying glass method, residual protein detection method, real-time PCR, and agar pour plate method.
RESULTS: Twenty five used protective hoods underwent totally 135 times of washing, disinfecting and sterilizing procedures. After washing, all the protein residue tests and COVID-19 nucleic acid tests showed negative results. After sterilizing, all the protective hoods met sterility requirement. All the tested protective hoods were undamaged after reprocessing.
CONCLUSIONS: The established reuse procedures for used positive pressure powered air-filter protective hoods are safe.

Entities:  

Keywords:  Cleaning; Coronavirus disease 2019; Positive pressure powered air-filter protective hood; Process; Reuse; Severe acute respiratory coronavirus 2; Sterilization

Mesh:

Year:  2020        PMID: 33210487      PMCID: PMC8800687          DOI: 10.3785/j.issn.1008-9292.2020.10.09

Source DB:  PubMed          Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban        ISSN: 1008-9292


  3 in total

1.  [Study on the performances of the positive pressure powered air-filter protective hood].

Authors:  Feng Tian; Zheng Wang; Jingquan Yang; Jian Yang; Shenjun Liu; Yanjun Zhang
Journal:  Sheng Wu Yi Xue Gong Cheng Xue Za Zhi       Date:  2006-08

2.  [Pancytopenia in disseminated tuberculosis: Think of macrophage activation syndrome].

Authors:  H Le Hô; N Barbarot; B Desrues
Journal:  Rev Mal Respir       Date:  2010-03-16       Impact factor: 0.622

3.  Anaesthesia and SARS.

Authors:  Damon Kamming; Michael Gardam; Frances Chung
Journal:  Br J Anaesth       Date:  2003-06       Impact factor: 9.166

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.